{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T16:11:41Z","timestamp":1762272701994},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T00:00:00Z","timestamp":1617753600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T00:00:00Z","timestamp":1617753600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s11910-021-01113-2","type":"journal-article","created":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T02:02:35Z","timestamp":1617760955000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Cerebrovascular Complications Associated with Marijuana Use"],"prefix":"10.1007","volume":"21","author":[{"given":"Bayan","family":"Moustafa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando D.","family":"Testai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,7]]},"reference":[{"issue":"1","key":"1113_CR1","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1523\/JNEUROSCI.4503-03.2004","volume":"24","author":"M Melis","year":"2004","unstructured":"Melis M, Pistis M, Perra S, Muntoni AL, Pillolla G, Gessa GL. Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors. J Neurosci. 2004;24(1):53\u201362. https:\/\/doi.org\/10.1523\/JNEUROSCI.4503-03.2004.","journal-title":"J Neurosci"},{"issue":"10","key":"1113_CR2","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.tins.2009.06.004","volume":"32","author":"RA Wise","year":"2009","unstructured":"Wise RA. Roles for nigrostriatal--not just mesocorticolimbic--dopamine in reward and addiction. Trends Neurosci. 2009;32(10):517\u201324. https:\/\/doi.org\/10.1016\/j.tins.2009.06.004.","journal-title":"Trends Neurosci"},{"issue":"6441","key":"1113_CR3","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/365061a0","volume":"365","author":"S Munro","year":"1993","unstructured":"Munro S, Thomas KL, Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature. 1993;365(6441):61\u20135. https:\/\/doi.org\/10.1038\/365061a0.","journal-title":"Nature"},{"issue":"5090","key":"1113_CR4","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1126\/science.1470919","volume":"258","author":"WA Devane","year":"1992","unstructured":"Devane WA, Hanus L, Breuer A, Pertwee R, Stevenson L, Griffin G, et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 1992;258(5090):1946\u20139. https:\/\/doi.org\/10.1126\/science.1470919.","journal-title":"Science"},{"key":"1113_CR5","first-page":"118462","volume":"2020","author":"S Puhl","year":"1867","unstructured":"Puhl S. Cannabinoid-sensitive receptors in cardiac physiology and ischaemia. Biochim Biophys Acta. 1867;2020:118462.","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"1113_CR6","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.plipres.2011.01.001","volume":"50","author":"P Pacher","year":"2011","unstructured":"Pacher P, Mechoulam R. Is lipid signaling through cannabinoid 2 receptors part of a protective system? Prog Lipid Res. 2011;50(2):193\u2013211. https:\/\/doi.org\/10.1016\/j.plipres.2011.01.001.","journal-title":"Prog Lipid Res"},{"issue":"1","key":"1113_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41582-019-0284-z","volume":"16","author":"L Cristino","year":"2020","unstructured":"Cristino L, Bisogno T, Di Marzo V. Cannabinoids and the expanded endocannabinoid system in neurological disorders. Nat Rev Neurol. 2020;16(1):9\u201329. https:\/\/doi.org\/10.1038\/s41582-019-0284-z.","journal-title":"Nat Rev Neurol"},{"issue":"8","key":"1113_CR8","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1002\/cbdv.200790152","volume":"4","author":"MA Huestis","year":"2007","unstructured":"Huestis MA. Human cannabinoid pharmacokinetics. Chem Biodivers. 2007;4(8):1770\u2013804. https:\/\/doi.org\/10.1002\/cbdv.200790152.","journal-title":"Chem Biodivers"},{"key":"1113_CR9","doi-asserted-by":"crossref","unstructured":"Pertwee RG. Handbook of Cannabis.; 2014.","DOI":"10.1093\/acprof:oso\/9780199662685.001.0001"},{"issue":"14","key":"1113_CR10","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.2174\/092986710790980050","volume":"17","author":"RG Pertwee","year":"2010","unstructured":"Pertwee RG. Receptors and channels targeted by synthetic cannabinoid receptor agonists and antagonists. Curr Med Chem. 2010;17(14):1360\u201381. https:\/\/doi.org\/10.2174\/092986710790980050.","journal-title":"Curr Med Chem"},{"issue":"6","key":"1113_CR11","doi-asserted-by":"publisher","first-page":"966","DOI":"10.3732\/ajb.91.6.966","volume":"91","author":"KW Hillig","year":"2004","unstructured":"Hillig KW, Mahlberg PG. A chemotaxonomic analysis of cannabinoid variation in cannabis (Cannabaceae). Am J Bot. 2004;91(6):966\u201375. https:\/\/doi.org\/10.3732\/ajb.91.6.966.","journal-title":"Am J Bot"},{"issue":"4","key":"1113_CR12","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/j.1521-0391.2012.00240.x","volume":"21","author":"EW Gunderson","year":"2012","unstructured":"Gunderson EW, Haughey HM, Ait-Daoud N, Joshi AS, Hart CL. \"Spice\" and \"K2\" herbal highs: a case series and systematic review of the clinical effects and biopsychosocial implications of synthetic cannabinoid use in humans. Am J Addict. 2012;21(4):320\u20136.","journal-title":"Am J Addict"},{"issue":"20","key":"1113_CR13","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1056\/NEJMoa1714631","volume":"378","author":"O Devinsky","year":"2018","unstructured":"Devinsky O, Patel AD, Cross JH, Villanueva V, Wirrell EC, Privitera M, et al. Effect of cannabidiol on drop seizures in the Lennox-Gastaut syndrome. N Engl J Med. 2018;378(20):1888\u201397. https:\/\/doi.org\/10.1056\/NEJMoa1714631.","journal-title":"N Engl J Med"},{"issue":"21","key":"1113_CR14","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1056\/NEJMoa1611618","volume":"376","author":"O Devinsky","year":"2017","unstructured":"Devinsky O, Cross JH, Laux L, Marsh E, Miller I, Nabbout R, et al. Trial of cannabidiol for drug-resistant seizures in the Dravet syndrome. N Engl J Med. 2017;376(21):2011\u201320. https:\/\/doi.org\/10.1056\/NEJMoa1611618.","journal-title":"N Engl J Med"},{"key":"1113_CR15","doi-asserted-by":"crossref","unstructured":"Parmar JR, Forrest BD, Freeman RA. Medical marijuana patient counseling points for health care professionals based on trends in the medical uses, efficacy, and adverse effects of cannabis-based pharmaceutical drugs. Research in social and administrative pharmacy. ;12(4):638-654. 10.1016\/j.sapharm.2015.09.002.","DOI":"10.1016\/j.sapharm.2015.09.002"},{"issue":"6","key":"1113_CR16","doi-asserted-by":"publisher","first-page":"705","DOI":"10.2174\/1871527316666170321124949","volume":"16","author":"S Brotini","year":"2017","unstructured":"Brotini S, Schievano C, Guidi L. Ultra-micronized palmitoylethanolamide: an efficacious adjuvant therapy for Parkinson's disease. CNS Neurol Disord Drug Targets. 2017;16(6):705\u201313. https:\/\/doi.org\/10.2174\/1871527316666170321124949.","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"1","key":"1113_CR17","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/gps.1828","volume":"23","author":"MJ Passmore","year":"2008","unstructured":"Passmore MJ. The cannabinoid receptor agonist nabilone for the treatment of dementia-related agitation. International journal of geriatric psychiatry. 2008;23(1):116\u20137. https:\/\/doi.org\/10.1002\/gps.1828.","journal-title":"International journal of geriatric psychiatry"},{"key":"1113_CR18","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.msard.2017.06.015","volume":"17","author":"S Giacoppo","year":"2017","unstructured":"Giacoppo S, Bramanti P, Mazzon E. Sativex in the management of multiple sclerosis-related spasticity: an overview of the last decade of clinical evaluation. Multiple sclerosis and related disorders. 2017;17:22\u201331. https:\/\/doi.org\/10.1016\/j.msard.2017.06.015.","journal-title":"Multiple sclerosis and related disorders"},{"key":"1113_CR19","unstructured":"Abuse, National Institute on Drug. Marijuana use at historic highs among college-age adults. National Institute on drug abuse web site. https:\/\/www.drugabuse.gov\/news-events\/news-releases\/2019\/09\/marijuana-use-at-historic-highs-among-college-age-adults. Updated 2019."},{"issue":"5","key":"1113_CR20","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1056\/NEJM197208032870501","volume":"287","author":"P Beaconsfield","year":"1972","unstructured":"Beaconsfield P, Ginsburg J, Rainsbury R. Marihuana smoking. Cardiovascular effects in man and possible mechanisms. N Engl J Med. 1972;287(5):209\u201312. https:\/\/doi.org\/10.1056\/NEJM197208032870501.","journal-title":"N Engl J Med"},{"issue":"7","key":"1113_CR21","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.tcm.2018.11.004","volume":"29","author":"S Rezkalla","year":"2019","unstructured":"Rezkalla S, Kloner RA. Cardiovascular effects of marijuana. Trends in cardiovascular medicine. 2019;29(7):403\u20137. https:\/\/doi.org\/10.1016\/j.tcm.2018.11.004.","journal-title":"Trends in cardiovascular medicine"},{"issue":"23","key":"1113_CR22","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1161\/01.cir.103.23.2805","volume":"103","author":"MA Mittleman","year":"2001","unstructured":"Mittleman MA, Lewis RA, Maclure M, Sherwood JB, Muller JE. Triggering myocardial infarction by marijuana. Circulation. 2001;103(23):2805\u20139. https:\/\/doi.org\/10.1161\/01.cir.103.23.2805.","journal-title":"Circulation"},{"issue":"9","key":"1113_CR23","doi-asserted-by":"publisher","first-page":"480","DOI":"10.2459\/JCM.0000000000000681","volume":"19","author":"A Kalla","year":"2018","unstructured":"Kalla A, Krishnamoorthy PM, Gopalakrishnan A, Figueredo VM. Cannabis use predicts risks of heart failure and cerebrovascular accidents: results from the National Inpatient Sample. Journal of cardiovascular medicine. 2018;19(9):480\u20134. https:\/\/doi.org\/10.2459\/JCM.0000000000000681.","journal-title":"Journal of cardiovascular medicine"},{"issue":"3","key":"1113_CR24","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1111\/j.1476-5381.2010.00712.x","volume":"160","author":"M Rajesh","year":"2010","unstructured":"Rajesh M, Mukhopadhyay P, Hask\u00f3 G, Liaudet L, Mackie K. Pacher P\u00e1. Cannabinoid-1 receptor activation induces reactive oxygen species-dependent and -independent mitogen-activated protein kinase activation and cell death in human coronary artery endothelial cells. Br J Pharmacol. 2010;160(3):688\u2013700. https:\/\/doi.org\/10.1111\/j.1476-5381.2010.00712.x.","journal-title":"Br J Pharmacol"},{"issue":"7","key":"1113_CR25","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s00109-013-1034-0","volume":"91","author":"S Slavic","year":"2013","unstructured":"Slavic S, Lauer D, Sommerfeld M, Kemnitz UR, Grzesiak A, Trappiel M, et al. Cannabinoid receptor 1 inhibition improves cardiac function and remodelling after myocardial infarction and in experimental metabolic syndrome. J Mol Med (Berl). 2013;91(7):811\u201323. https:\/\/doi.org\/10.1007\/s00109-013-1034-0.","journal-title":"J Mol Med (Berl)"},{"issue":"1","key":"1113_CR26","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1161\/CIRCULATIONAHA.108.811992","volume":"119","author":"K Sugamura","year":"2009","unstructured":"Sugamura K, Sugiyama S, Nozaki T, Matsuzawa Y, Izumiya Y, Miyata K, et al. Activated endocannabinoid system in coronary artery disease and antiinflammatory effects of cannabinoid 1 receptor blockade on macrophages. Circulation. 2009;119(1):28\u201336. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.108.811992.","journal-title":"Circulation"},{"issue":"8","key":"1113_CR27","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1007\/s00125-008-1048-2","volume":"51","author":"V Di Marzo","year":"2008","unstructured":"Di Marzo V. The endocannabinoid system in obesity and type 2 diabetes. Diabetologia. 2008;51(8):1356\u201367. https:\/\/doi.org\/10.1007\/s00125-008-1048-2.","journal-title":"Diabetologia"},{"issue":"2","key":"1113_CR28","doi-asserted-by":"publisher","first-page":"e141","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.08.013","volume":"23","author":"A Nouh","year":"2014","unstructured":"Nouh A, Ruland S, Schneck MJ, Pasquale D, Biller J. Reversible cerebral vasoconstriction syndrome with multivessel cervical artery dissections and a double aortic arch. J Stroke Cerebrovasc Dis. 2014;23(2):e141\u20133. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2013.08.013.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"12","key":"1113_CR29","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1212\/WNL.0b013e3182a4a451","volume":"81","author":"AB Singhal","year":"2013","unstructured":"Singhal AB, Biller J, Elkind MS, Fullerton HJ, Jauch EC, Kittner SJ, et al. Recognition and management of stroke in young adults and adolescents. Neurology. 2013;81(12):1089\u201397. https:\/\/doi.org\/10.1212\/WNL.0b013e3182a4a451.","journal-title":"Neurology"},{"issue":"5","key":"1113_CR30","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1177\/1747493019895651","volume":"15","author":"R Desai","year":"2020","unstructured":"\u2022 Desai R, Singh S, Patel K, et al. Stroke in young cannabis users (18\u201349 years): national trends in hospitalizations and outcomes. Int J Stroke. 2020;15(5):535\u20139. https:\/\/doi.org\/10.1177\/1747493019895651Large study describing the association of cannabins use with stroke in young patients.","journal-title":"Int J Stroke"},{"issue":"3","key":"1113_CR31","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1161\/STROKEAHA.115.008680","volume":"46","author":"DG Hackam","year":"2015","unstructured":"Hackam DG. Cannabis and stroke: systematic appraisal of case reports. Stroke. 2015;46(3):852\u20136. https:\/\/doi.org\/10.1161\/STROKEAHA.115.008680.","journal-title":"Stroke"},{"issue":"1","key":"1113_CR32","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1161\/STROKEAHA.119.027828","volume":"51","author":"T Parekh","year":"2020","unstructured":"Parekh T, Pemmasani S, Desai R. Marijuana use among young adults (18-44 years of age) and risk of stroke: a behavioral risk factor surveillance system survey analysis. Stroke. 2020;51(1):308\u201310. https:\/\/doi.org\/10.1161\/STROKEAHA.119.027828.","journal-title":"Stroke"},{"key":"1113_CR33","doi-asserted-by":"publisher","unstructured":"Shah S, Patel S, Paulraj S, Chaudhuri D. Association of marijuana use and cardiovascular disease: A behavioral risk factor surveillance system data analysis of 133,706 US adults. Am J Med. 2020. https:\/\/doi.org\/10.1016\/j.amjmed.2020.10.019.","DOI":"10.1016\/j.amjmed.2020.10.019"},{"key":"1113_CR34","unstructured":"Liu M, Nabavizadeh J, Rao P, Derakhshandeh P, Springer R. Impairment of endothelial function by aerosol from marijuana leaf vaporizers. Circulation."},{"issue":"6","key":"1113_CR35","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1161\/STROKEAHA.110.610915","volume":"42","author":"V Wolff","year":"2011","unstructured":"Wolff V, Lauer V, Rouyer O, Sellal F, Meyer N, Raul JS, et al. Cannabis use, ischemic stroke, and multifocal intracranial vasoconstriction: a prospective study in 48 consecutive young patients. Stroke. 2011;42(6):1778\u201380. https:\/\/doi.org\/10.1161\/STROKEAHA.110.610915.","journal-title":"Stroke"},{"issue":"2","key":"1113_CR36","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1161\/STROKEAHA.112.671347","volume":"44","author":"V Wolff","year":"2013","unstructured":"Wolff V, Armspach J, Lauer V, et al. Cannabis-related stroke: myth or reality? Stroke. 2013;44(2):558\u201363. https:\/\/doi.org\/10.1161\/STROKEAHA.112.671347.","journal-title":"Stroke"},{"issue":"8","key":"1113_CR37","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1161\/STROKEAHA.119.024416","volume":"50","author":"TM Burton","year":"2019","unstructured":"Burton TM, Bushnell CD. Reversible cerebral vasoconstriction syndrome. Stroke. 2019;50(8):2253\u20138. https:\/\/doi.org\/10.1161\/STROKEAHA.119.024416.","journal-title":"Stroke"},{"key":"1113_CR38","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.1093\/brain\/awm256","volume":"130","author":"A Ducros","year":"2007","unstructured":"Ducros A, Boukobza M, Porcher R, Sarov M, Valade D, Bousser M. The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients. Brain. 2007;130:3091\u2013101. https:\/\/doi.org\/10.1093\/brain\/awm256.","journal-title":"Brain"},{"issue":"3","key":"1113_CR39","first-page":"649","volume":"196","author":"MD Adams","year":"1976","unstructured":"Adams MD, Earnhardt JT, Dewey WL, Harris LS. Vasoconstrictor actions of delta8- and delta9-tetrahydrocannabinol in the rat. J Pharmacol Exp Ther. 1976;196(3):649\u201356.","journal-title":"J Pharmacol Exp Ther"},{"key":"1113_CR40","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Richter JS, Quenardelle V, Rouyer O, et al.. 2018 A systematic review of the complex effects of cannabinoids on cerebral and peripheral circulation in animal models. Front Physiol. 9. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5986896\/. 10.3389\/fphys.2018.00622. Comprehensive review on the effect of cannabinois on the cerebral circulation in preclinical models","DOI":"10.3389\/fphys.2018.00622"},{"issue":"3","key":"1113_CR41","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1212\/01.WNL.0000150882.69371.DD","volume":"64","author":"RI Herning","year":"2005","unstructured":"Herning RI, Better WE, Tate K, Cadet JL. Cerebrovascular perfusion in marijuana users during a month of monitored abstinence. Neurology. 2005;64(3):488\u201393. https:\/\/doi.org\/10.1212\/01.WNL.0000150882.69371.DD.","journal-title":"Neurology"},{"key":"1113_CR42","doi-asserted-by":"publisher","first-page":"323706","DOI":"10.1155\/2015\/323706","volume":"2015","author":"V Wolff","year":"2015","unstructured":"Wolff V, Schlagowski A, Rouyer O, et al. Tetrahydrocannabinol induces brain mitochondrial respiratory chain dysfunction and increases oxidative stress: a potential mechanism involved in cannabis-related stroke. Biomed Res Int. 2015;2015:323706\u20137. https:\/\/doi.org\/10.1155\/2015\/323706.","journal-title":"Biomed Res Int"},{"key":"1113_CR43","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.3389\/fphar.2019.01481","volume":"10","author":"SR Archie","year":"2019","unstructured":"\u2022\u2022 Archie SR, Cucullo L. Harmful effects of smoking cannabis: a cerebrovascular and neurological perspective. Front Pharmacol. 2019;10:1481. https:\/\/doi.org\/10.3389\/fphar.2019.01481Thougful review on the cerebrovascular and neurologic effects of cannabis.","journal-title":"Front Pharmacol"},{"issue":"2","key":"1113_CR44","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/j.1600-0447.1992.tb03247.x","volume":"86","author":"RJ Mathew","year":"1992","unstructured":"Mathew RJ, Wilson WH, Humphreys D, Lowe JV, Wiethe KE. Middle cerebral artery velocity during upright posture after marijuana smoking. Acta Psychiatr Scand. 1992;86(2):173\u20138. https:\/\/doi.org\/10.1111\/j.1600-0447.1992.tb03247.x.","journal-title":"Acta Psychiatr Scand"},{"issue":"8","key":"1113_CR45","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1097\/HJH.0000000000000990","volume":"34","author":"O Alshaarawy","year":"2016","unstructured":"Alshaarawy O, Elbaz HA. Cannabis use and blood pressure levels: United States national health and nutrition examination survey, 2005-2012. J Hypertens. 2016;34(8):1507\u201312. https:\/\/doi.org\/10.1097\/HJH.0000000000000990.","journal-title":"J Hypertens"},{"issue":"8","key":"1113_CR46","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1016\/j.mayocp.2019.05.008","volume":"94","author":"T Chami","year":"2019","unstructured":"Chami T, Kim CH. Cannabis abuse and elevated risk of myocardial Infarction in the young: a population-based study. Mayo Clin Proc. 2019;94(8):1647\u20139. https:\/\/doi.org\/10.1016\/j.mayocp.2019.05.008.","journal-title":"Mayo Clin Proc"},{"key":"1113_CR47","doi-asserted-by":"publisher","unstructured":"Desai R, Patel U, Sharma S, et al. Recreational marijuana use and acute myocardial infarction: insights from nationwide inpatient sample in the United States. Cureus. ;9(11). https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5752226\/. https:\/\/doi.org\/10.7759\/cureus.1816.","DOI":"10.7759\/cureus.1816"},{"key":"1113_CR48","doi-asserted-by":"publisher","unstructured":"Jaladi PR, Patel V, Kuduva Rajan S, et al. Arrhythmia-related Hospitalization and comorbid cannabis use disorder: trend analysis in US hospitals (2010-2014). Cureus. ;11(9). https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6822885\/. https:\/\/doi.org\/10.7759\/cureus.5607.","DOI":"10.7759\/cureus.5607"},{"issue":"3","key":"1113_CR49","doi-asserted-by":"publisher","first-page":"187","DOI":"10.7326\/M17-1548","volume":"168","author":"D Ravi","year":"2018","unstructured":"Ravi D, Ghasemiesfe M, Korenstein D, Cascino T, Keyhani S. Associations between marijuana use and cardiovascular risk factors and outcomes: a systematic review. Ann Intern Med. 2018;168(3):187\u201394. https:\/\/doi.org\/10.7326\/M17-1548.","journal-title":"Ann Intern Med"},{"issue":"1","key":"1113_CR50","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1186\/s12916-020-01804-6","volume":"18","author":"N Auger","year":"2020","unstructured":"\u2022 Auger N, Paradis G, Low N, Ayoub A, He S, Potter BJ. Cannabis use disorder and the future risk of cardiovascular disease in parous women: a longitudinal cohort study. BMC Med. 2020;18(1):328. https:\/\/doi.org\/10.1186\/s12916-020-01804-6Large longitudinal cohort that investigated the risk of major vascular complications in cannabis users.","journal-title":"BMC Med"},{"issue":"4","key":"1113_CR51","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1001\/archpsyc.64.4.495","volume":"64","author":"AN Westover","year":"2007","unstructured":"Westover AN, McBride S, Haley RW. Stroke in young adults who abuse amphetamines or cocaine: a population-based study of hospitalized patients. Arch Gen Psychiatry. 2007;64(4):495\u2013502. https:\/\/doi.org\/10.1001\/archpsyc.64.4.495.","journal-title":"Arch Gen Psychiatry"},{"issue":"12","key":"1113_CR52","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.08.011","volume":"27","author":"K Malhotra","year":"2018","unstructured":"Malhotra K, Rumalla K, Mittal MK. Association and clinical outcomes of marijuana in patients with intracerebral hemorrhage. J Stroke Cerebrovasc Dis. 2018;27(12):3479\u201386. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2018.08.011.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"5-6","key":"1113_CR53","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1159\/000443532","volume":"41","author":"M Di Napoli","year":"2016","unstructured":"Di Napoli M, Zha AM, Godoy DA, et al. Prior cannabis use is associated with outcome after intracerebral hemorrhage. Cerebrovasc Dis. 2016;41(5-6):248\u201355. https:\/\/doi.org\/10.1159\/000443532.","journal-title":"Cerebrovasc Dis"},{"issue":"2","key":"1113_CR54","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.10.019","volume":"25","author":"K Rumalla","year":"2016","unstructured":"Rumalla K, Reddy AY, Mittal MK. Association of recreational marijuana use with aneurysmal subarachnoid hemorrhage. J Stroke Cerebrovasc Dis. 2016;25(2):452\u201360. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2015.10.019.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"5","key":"1113_CR55","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1161\/STROKEAHA.116.013099","volume":"47","author":"R Behrouz","year":"2016","unstructured":"Behrouz R, Birnbaum L, Grandhi R, Johnson J, Misra V, Palacio S, et al. Cannabis use and outcomes in patients with aneurysmal subarachnoid hemorrhage. Stroke. 2016;47(5):1371\u20133. https:\/\/doi.org\/10.1161\/STROKEAHA.116.013099.","journal-title":"Stroke"},{"key":"1113_CR56","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jocn.2019.12.066","volume":"72","author":"C Dandurand","year":"2020","unstructured":"Dandurand C, Ke JXC, Mekary RA, Prakash S, Redekop G, Gooderham P, et al. Cannabis use and outcomes after aneurysmal subarachnoid hemorrhage: a nationwide retrospective cohort study. J Clin Neurosci. 2020;72:98\u2013101. https:\/\/doi.org\/10.1016\/j.jocn.2019.12.066.","journal-title":"J Clin Neurosci"},{"issue":"10","key":"1113_CR57","doi-asserted-by":"publisher","first-page":"e131","DOI":"10.1161\/CIR.0000000000000883","volume":"142","author":"RL Page","year":"2020","unstructured":"\u2022\u2022 Page RL, Allen LA, Kloner RA, et al. Medical marijuana, recreational cannabis, and cardiovascular health: a scientific statement from the American heart association. Circulation. 2020;142(10):e131\u201352. https:\/\/doi.org\/10.1161\/CIR.0000000000000883Comprehensive review on the effect of cannabinois on cardiovascular health, including cardiovascular outcomes and drug-drug interactions.","journal-title":"Circulation"},{"issue":"13","key":"1113_CR58","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1056\/NEJMoa1807652","volume":"379","author":"AH Kelkar","year":"2018","unstructured":"Kelkar AH, Smith NA, Martial A, Moole H, Tarantino MD, Roberts JC. An outbreak of synthetic cannabinoid\u2013associated coagulopathy in Illinois. N Engl J Med. 2018;379(13):1216\u201323. https:\/\/doi.org\/10.1056\/NEJMoa1807652.","journal-title":"N Engl J Med"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-021-01113-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11910-021-01113-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-021-01113-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T01:57:35Z","timestamp":1619661455000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11910-021-01113-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,7]]},"references-count":58,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["1113"],"URL":"https:\/\/doi.org\/10.1007\/s11910-021-01113-2","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,7]]},"assertion":[{"value":"23 March 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}},{"value":"Bayan Moustafa and Fernando D. Testai each declare no potential conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"25"}}